These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4921005)

  • 1. [Oral immunization of mice with Shigella sonnei antigens].
    Thilo W; Weister A
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):294-302. PubMed ID: 4921005
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin.
    Kowalewska D; Mulczyk M
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):99-102. PubMed ID: 4613143
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nonspecific nature of antibody formation suppression by virulent Shigella sonnei].
    Borisov VA; Frolov AF
    Mikrobiol Zh (1978); 1982; 44(1):71-6. PubMed ID: 7040918
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on acquired systemic resistance in mice with oral immunization with Shigella sonnei.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):345-55. PubMed ID: 7004395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune processes induced by dysentery bacilli in mice.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):595-601. PubMed ID: 373684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of Shigella virulence in the formation of an immune response in dysentery].
    Borisov VA; Zagornaia NB
    Mikrobiol Zh (1978); 1980; 42(2):214-8. PubMed ID: 6991890
    [No Abstract]   [Full Text] [Related]  

  • 7. [Shigella interaction with immune enterocytes].
    Polotskiĭ IuE; Seliverstova VG; Rukhamina ML; Krasnoproshina LI
    Arkh Patol; 1980; 42(12):39-46. PubMed ID: 7011272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive transfer of immunity to dysentery bacilli with immune T lymphocytes from mice orally immunized with Shigella sonnei bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):593-601. PubMed ID: 7006564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of the synergistic action of enterotoxin on the specific protective complex of Shigella sonnei].
    Korneeva SA; Kovalevskaia IL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Dec; (12):38-41. PubMed ID: 1789032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune processes in the course of infection with dysentery bacilli. III. Protective activity of spleen cells and serum from mice immunized with killed dysentery bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1977; 25(1):69-78. PubMed ID: 327970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipopolysaccharides of Shigella sonnei].
    Borisova EV; Borisov VA
    Prikl Biokhim Mikrobiol; 2000; 36(5):597-602. PubMed ID: 11042887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of shigellae on delayed hypersensitivity in mice infected by different routes].
    Borisov VA; Borisova EV; Solov'eva GA
    Mikrobiol Z; 1994; 56(3):55-9. PubMed ID: 7952228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory control of oral Shigella sonnei vaccine.
    Starke G; Thilo W
    Prog Immunobiol Stand; 1970; 4():363-7. PubMed ID: 4921390
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune processes in the course of infection with dysentery bacilli. I. Transfer of immunity by means of spleen cells.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1976; 24(3):315-26. PubMed ID: 786209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological interrelations between Shigella sonnei differing in enzymatic activity and colicinogenicity].
    Toluzakova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Feb; (2):91-4. PubMed ID: 6369844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of crossed immunity between different serotypes of dysentery bacilli and the keratoconjunctivitis-positive, lactoso-negative strain 47552 deprived of Shigella agglutinogen].
    Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):389-94. PubMed ID: 4925072
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quantitative determination of Shigella sonnei antigens in urine of patients and bacterial carriers].
    Godovannyĭ BA; Litinskiĭ IuI; Bodisko VP; Demchenko MP; Mil'man EM; Karimova DKh; Khazanova LB; Trubolysova MA; Dul'tseva LP
    Lab Delo; 1970; 6():360-3. PubMed ID: 4195715
    [No Abstract]   [Full Text] [Related]  

  • 19. Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions.
    Bedford L; Fonseka S; Boren T; Ranallo RT; Suvarnapunya AE; Lee JE; Barnoy S; Venkatesan MM
    Gut Microbes; 2011; 2(4):244-51. PubMed ID: 21983066
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study on the effectiveness of a Sh. sonnei oral vaccine using the direct plaque technic].
    Thilo W; Seeger E; Schlosshardt J; Kriehn I; Poeplau A
    Z Gesamte Hyg; 1972 Oct; 18(10):756-8. PubMed ID: 4581673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.